Irwin CHEN

Person

Santa Monico, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific antibody construct directed to MUC17 and CD3
- Patent number 12,258,404
- Issue date Mar 25, 2025
- Amgen Inc.
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody constructs for CLDN18.2 and CD3
- Patent number 11,692,031
- Issue date Jul 4, 2023
- Amgen Research (Munich) GmbH
- Christoph Dahlhoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptide PAC1 antagonists
- Patent number 11,643,440
- Issue date May 9, 2023
- Amgen Inc.
- Irwin Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-human TREM2 antibodies and uses thereof
- Patent number 11,186,636
- Issue date Nov 30, 2021
- Amgen Inc.
- Ian Foltz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitory polypeptides specific to WNT inhibitors
- Patent number 9,708,375
- Issue date Jul 18, 2017
- Amgen Inc.
- Ryan B. Case
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Antibody Constructs for CLDN18.2 and CD3
- Publication number 20240174745
- Publication date May 30, 2024
- AMGEN RESEARCH (MUNICH) GMBH
- Christoph Dahlhoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PAC1 ANTIBODIES AND USES THEREOF
- Publication number 20240150448
- Publication date May 9, 2024
- Amgen Inc.
- Neeraj Jagdish AGRAWAL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CGRP RECEPTOR/ANTI-PAC1 RECEPTOR BISPECIFIC ANTIGEN BINDING PR...
- Publication number 20220363770
- Publication date Nov 17, 2022
- Amgen Inc.
- Irwin CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREM2 ANTIGEN BINDING PROTEINS AND USES THEREOF
- Publication number 20220204611
- Publication date Jun 30, 2022
- Amgen Inc.
- Ian N. FOLTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PAC1 ANTIBODIES AND USES THEREOF
- Publication number 20220195022
- Publication date Jun 23, 2022
- Amgen Inc.
- Neeraj Jagdish AGRAWAL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PEPTIDE PAC1 ANTAGONISTS
- Publication number 20210395313
- Publication date Dec 23, 2021
- Amgen Inc.
- Irwin CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Antibody Construct Directed to MUC17 and CD3
- Publication number 20210130465
- Publication date May 6, 2021
- Amgen Inc.
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDIN...
- Publication number 20210087286
- Publication date Mar 25, 2021
- Amgen Inc.
- Darren L. BATES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREM2 Antigen Binding Proteins And Uses Thereof
- Publication number 20210054069
- Publication date Feb 25, 2021
- Amgen Inc.
- Ian Foltz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PAC1 ANTIBODIES AND USES THEREOF
- Publication number 20210017261
- Publication date Jan 21, 2021
- Amgen Inc.
- Neeraj Jagdish AGRAWAL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Constructs for CLDN18.2 and CD3
- Publication number 20200055932
- Publication date Feb 20, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Christoph Dahlhoff
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PAC1 ANTIBODIES AND USES THEREOF
- Publication number 20190218279
- Publication date Jul 18, 2019
- Amgen Inc.
- Neeraj Jagdish AGRAWAL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitory Polypeptides Specific to WNT Inhibitors
- Publication number 20160024158
- Publication date Jan 28, 2016
- Ryan B. CASE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Bispecific antibody construct directed to MUC17 and CD3

Antibody constructs for CLDN18.2 and CD3

Peptide PAC1 antagonists

Anti-human TREM2 antibodies and uses thereof

Inhibitory polypeptides specific to WNT inhibitors

Patents Applicationslast 30 patents

Antibody Constructs for CLDN18.2 and CD3

PAC1 ANTIBODIES AND USES THEREOF

ANTI-CGRP RECEPTOR/ANTI-PAC1 RECEPTOR BISPECIFIC ANTIGEN BINDING PR...

TREM2 ANTIGEN BINDING PROTEINS AND USES THEREOF

PAC1 ANTIBODIES AND USES THEREOF

PEPTIDE PAC1 ANTAGONISTS

Bispecific Antibody Construct Directed to MUC17 and CD3

METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDIN...

TREM2 Antigen Binding Proteins And Uses Thereof

PAC1 ANTIBODIES AND USES THEREOF

Antibody Constructs for CLDN18.2 and CD3

PAC1 ANTIBODIES AND USES THEREOF

Inhibitory Polypeptides Specific to WNT Inhibitors